Pharmaceutical

STAT+: Feng Zhang, Grail founder join forces on new gen...

A new startup co-founded by Feng Zhang aims to develop treatments for a variety ...

STAT+: Novo Nordisk enlists two Flagship biotechs to de...

The Danish drugmaker Novo Nordisk is enlisting two Flagship biotechs to develop ...

STAT+: Burning questions for the 2024 JPM Healthcare Co...

Here’s our list of burning questions facing the health care industry as much of ...

Opinion: Insurance companies are forcing psychiatrists ...

Insurance companies are forcing psychiatrists to stop accepting their coverage.

STAT+: Health tech’s 2024 hiring outlook: Balance tips ...

It might feel like a downturn, but more likely, the health technology industry i...

After loved ones’ long-awaited organ transplants, careg...

Caregivers for people who receive organ transplants say there is often little su...

STAT+: Veteran biotech entrepreneur Harvey Berger to le...

Veteran biotech entrepreneur Harvey Berger is the new chief executive of venture...

Anavex’s slow journey to failure

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: FDA approvals rebound, abortion pi...

The FDA approved nearly 50% more novel drugs in 2023 than in 2022, putting it ba...

STAT+: Goldman Sachs launches $650 million fund for lif...

Investment bank Goldman Sachs is jumping into the biotech world after raising $6...

EMA validates BMS’s repotrectinib application to treat ...

The EMA has validated the marketing authorisation application of Bristol Myers S...

MediLink and Roche partner on cancer drug development

MediLink Therapeutics has signed a global partnership and licence deal with Roch...

PDS-01ADC by PDS Biotechnology for Colorectal Cancer: L...

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Ph...

Boehringer reinforces interest in NASH with new $2bn de...

This collaboration comes six years after the German company Boehringer signed tw...

Novartis allies with Voyager to develop gene therapies ...

Novartis will pay Voyager $100m upfront and up to $1.2bn in milestone-based paym...

Signal: FTC granted injunction to pause IQVIA’s acquisi...

A US court has granted the FTC's request to halt the acquisition due to concerns...